Previously, we determined microRNA-31 (miR-31) is a noncoding tumor suppressive gene frequently deleted in glioblastoma (GBM); miR-31 suppresses tumor growth, in part, by limiting the activity of NF-jB. Herein, we expand our previous studies by characterizing the role of miR-31 during neural precursor cell (NPC) to astrocyte differentiation. We demonstrate that miR-31 expression and activity is suppressed in NPCs by stem cell factors such as Lin28, c-Myc, SOX2 and Oct4. However, during astrocytogenesis, miR-31 is induced by STAT3 and SMAD1/5/8, which mediate astrocyte differentiation. We determined miR-31 is required for terminal astrocyte differentiation, and that the loss of miR-31 impairs this process and/or prevents astrocyte maturation.
to astrocyte differentiation is mediated by multiple factors/signaling molecules, including JAK/STAT3, BMP/Smads, NFIA, and SOX9 (Dirks, 2006; Gallo & Deneen, 2014; Kim, Huang, Park, Park, & Johnson, 2011; Sieber, Kopf, Hiepen, & Knaus, 2009 ). Together, Smads, STAT3, NFIA, and SOX9 establish the transcriptional profile that mediates astrocytogenesis (Deneen et al., 2006; Fukuda et al., 2007; Gallo & Deneen, 2014; Glasgow et al., 2014b; Kang et al., 2012) .
MiRs are short, endogenous noncoding RNAs that bind to target mRNAs in order to prevent their translation or reduce their stability (Lujambio & Lowe, 2012) . MiR-31 is a noncoding tumor suppressor encoded by the MIR31HG gene located at 9p21.3, the most frequently deleted region in GBM (Rajbhandari et al., 2015) . Previously, we demonstrated that one or both copies of MIR31HG are deleted in GBM, and that miR-31 restoration reduced tumor growth and improved survival in mouse models of GBM (Rajbhandari et al., 2015) . Herein, we expand these findings and elaborate on the role of miR-31 during normal astrocyte development within the CNS. We find Lin28, Oct4 and SOX2 inhibit miR-31 expression and activity in NPCs. However, during astrocytogenesis, STAT3 and SMAD1/5/8 increase the levels of miR-31. Alone, exogenous miR-31 can partially promote astrocyte differentiation of NPCs; this is in part by targeting the stem cell factor Lin28. In the absence of miR-31, NPCs fail to fully differentiate into astrocytes.
Finally, in astrocytes, we demonstrate that loss of miR-31 prevents astrocyte maturation and causes these cells to assume a more NPC-like phenotype. Collectively, these data indicate that miR-31 is critical for astrocyte development and/or commitment.
| M A TE RI A L S A ND M E TH ODS

| Reagents
IL-1b and TNF-a were from R & D Systems. The secondary peroxidase-conjugated antibodies and enhanced chemiluminescence reagents were purchased from Amersham (Arlington Heights, IL). Anti-KLF4, anti-Lin28, anti-Nestin, anti-Oct4, and anti-SOX2 antibodies were from Santa Cruz. Anti-Olig2 antibodies were purchased from R & D Systems. Anti-GFAP antibodies were from Pharmingen, and antiBrn2 (POU3F2) and anti-GAPDH antibodies were from Abcam. Taqman qRT-PCR reagents were from Applied Biosystems (Beverly, MA).
Sybr green qRT-PCR reagents were from Qiagen (Valencia, CA). All other primers were purchased from Integrated DNA Technologies (Iowa City, IA). MicroRNA-31 mimic, miR-31 AntagomiR and negative control (CT) miR were purchased from Ambion/Life Technologies (Austin, TX). MicroRNAs and shRNA molecules were transfected using Lipofectamine RNAiMax Transfection reagent (Life Technologies, Grand Island, NY). Control and Lin28 specific shRNA were purchased from Dharmacon.
| Immunofluorescence
Where indicated, cells or cryosections were post-fixed in 4% PFA for 5 min at room temperature followed by three 5-min washes in phosphate buffered saline (PBS) followed by a methanol treatment at 2208C for 15 min. Sections were then washed with PBS followed by permeabilization and blocking with 0.3% Triton X-100 in PBS with 2% donkey serum, 0.02% sodium azide and 10 mg/ml bovine serum albumin (BSA).
Sections were then labeled with antibodies indicated, washed in PBS with 2% normal donkey serum, 0.02% sodium azide and 10 mg/ml BSA, and incubated in secondary antibody (1:1000, Alex Fluor-594, A-21203, Invitrogen, Carlsbad, CA). Nuclei were visualized by DAPI nuclear stain (Invitrogen). Sections were mounted onto glass slides and mounted using DABCO mounting media (10 mg of DABCO D2522; SigmaAldrich, St. Louis, MO) in 1 ml of PBS and 9 ml of glycerol, and imaged using confocal microscopy (Koemeter-Cox et al., 2014) .
| Immunoblotting
Cells were lysed in RIPA buffer with protease inhibitors and protein concentration was determined using the BioRad dye-binding protein assay. Equivalent amounts of total protein were analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis with antibodies specified above, as previously described (McFarland et al., 2013; Rajbhandari et al., 2015) .
| Mice and primary cell preparations
Normal primary murine NPCs were prepared as previously described (Meares et al., 2014) . NPCs were plated in Neurobasal media with Amphotericin (1%), B27 Supplement minus vitamin A, Gentamycin (0.25%), L-glutamine (260 mM), epidermal growth factor (10 ng/ml), and fibroblast growth factor (10 ng/ml) and cultured as neurospheres. NPC identity was confirmed by flow cytometry using antibodies specific for SOX2, Nestin and GFAP. Where appropriate, untreated and treated NPCs were grown as adherent cultures on laminin (1.2 mg/ml) and poly-D-lysine (62.5 mg/ml) coated plates. To induce differentiation, NPCs were cultured with 10% FBS or LIF (10 ng/ml) and/or BMP2 (10 ng/ml) for the times indicated. C57BL/6 mice were bred and housed in the animal facility at the University of Alabama in Birmingham under the care of the animal resources program. Primary murine astrocytes were prepared as previously described (Meares, Qin, Liu, Holdbrooks, & Benveniste, 2013) . Astrocytes were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% FBS, 16 mM HEPES, 13 nonessential amino acids, 2 mM L-glutamine, 100 units/ml penicillin, 100 lg/ml streptomycin, and 50 lg/ml gentamicin. Astrocytes were separated from microglia by shaking at 400 rpm for 2 hr, and astrocyte cultures contained >90% GFAP-positive cells, as determined by immunofluorescence microscopy.
2.5 | Total RNA and microRNA purification, and realtime qRT-PCR Total RNA was isolated as previously described (McFarland et al., 2013; Rajbhandari et al., 2015) . To assess mRNA expression levels, 1 mg of total RNA was reverse transcribed and analyzed by quantitative polymerase chain reaction (PCR). Reactions for each sample were performed in triplicate using a PCR protocol (958C activation for 10 min followed by 40 cycles of 958C for 15 s and 608C for 1 min) in an ABI
StepOnePlus Detection System (Applied Biosystems). DDCt values for genes were examined using Ct values generated by StepOnePlus software (Applied Biosystems). miRNA was purified using the miRvana miRNA isolation kit (Invitrogen, Grand Island, NY) according to manufacturer's protocol. For miRNA-31 analyses, 10 ng of miRNA was reverse transcribed and analyzed by quantitative PCR using a miR-31 specific first strand primer and probe/primer sets purchased from Applied Biosystem (Grand Island, NY).
| Whole mount in situ hybridization
The X. laevis embryos were collected at neurula stages and analyzed by whole mount in situ hybridization analyses for miR-31 and marker expression. In situ hybridization was performed as described (Harland, 1991; Nie & Chang, 2007) , using the neural or the epidermal probes described previously (Tien et al., 2015) . In situ hybridization of horizontal sections of embryonic murine brains (E14.5) was performed using a modified method (Bonev & Papalopulu, 2012) .
| ChIP assays
ChIP assays were performed as previously described (Nozell et al., 2008; Rajbhandari et al., 2015; Tien et al., 2015) . Immunoprecipitation was performed with 5 mg of the appropriate antibodies, and the immune complexes were absorbed with protein A beads (Upstate Cell Signaling Solutions, Charlottesville, VA) blocked with bovine serum albumin and salmon sperm DNA. Immunoprecipitated DNA was analyzed by qRT-PCR using Sybr Green reagents. Reactions for each sample were performed in triplicate using an ABI StepOnePlus Detection System (Applied Biosystems, Foster City, CA) and a PCR protocol comprising an initial 10 min incubation at 958C followed by 40 cycles of 15 s at 958C and 1 min at 608C. The raw data were analyzed using
StepOnePlus software (Applied Biosystems), and DDCt values for each gene in each sample were determined. (neural tube marker), and Snail2 (neural crest marker) were also analyzed as cell-specific markers (Tien et al., 2015) . At the mid neurula phase, the pattern of miR-31 expression appeared most similar to that of SOX2 expression, but did not appear similar to the patterns of XK70 or Snail2 (Figure 1c ). Double ISH of X. laevis embryos confirmed miR-31 (green arrow) was co-expressed with SOX2 (orange arrow) in the neural tube, but not with Snail2 (white arrow; right), which marks the neural crest ( Figure 1d ). These data indicate miR-31 may play an early role in neural but not epidermal or neural crest specification.
| Statistical analysis
Next, we assessed the role of miR-31 in later stages of CNS development using mice. MiR-31 levels were analyzed from whole murine brain samples of mice aged embryonic (E) E15 to parental (P) P70 by qRT-PCR; we found that miR-31 levels increased from E15 to P70 (Figure 1e) . We also evaluated Nestin, Lin28B, Oct4, and GFAP mRNA levels. Nestin marks NPCs, Lin28, and Oct4 are stem cell markers, and GFAP specifies astrocytes. At these same developmental stages, we found that the levels of Nestin, Lin28B, and Oct4 were diminished (Figure 1f) , while the levels of GFAP were increased ( Figure 1g ). Thus, the levels of miR-31 increase during astrocytogenesis (E15-P70) and correlate with elevated GFAP levels.
We also evaluated miR-31 expression in the developing mouse brain at E14.5 using ISH; samples were counterstained with DAPI to mark cell nuclei (Figure 2a, blue; i, iii, v) . This developmental stage (E14.5) marks the neurogenic-to-gliogenic switch (Liu et al., 2002; Martynoga, Drechsel, & Guillemot, 2012 TG is a mass of pseudounipolar neurons tightly enveloped by satellite glial cells (Erzurumlu, Chen, & Jacquin, 2006; Viana, 2011; Vit, Jasmin, Bhargava, & Ohara, 2006) , while the VZ and SVZ of the GE host pools of proliferating progenitor cells (Zechel, Zajac, Lonnerberg, Ibanez, & Linnarsson, 2014 ). These data demonstrate that miR-31 is expressed in host glial and progenitor cells during the neurogenic-to-gliogenic switch. 
| MicroRNA-31 is elevated in differentiated astrocytes
To ascertain which cells in the CNS expressed miR-31, we analyzed Gene Expression Omnibus (GEO) datasets. In rat, we found miR-31 was significantly more abundant in astrocytes compared with neurons, oligodendrocytes or microglia (GSE34614; Figure 2b) ; in Homo sapiens, miR-31 levels were elevated as astrocytes matured (GSE15888; Figure   2c ). To confirm these data, we compared miR-31 levels in primary murine astrocytes and NPCs; NPCs were isolated from E15 embryos and astrocytes isolated from newborn mice (P0). The murine neurogenic-gliogenic switch occurs at approximately E14.5, and afterwards NPCs are largely committed to producing astrocytes and oligodendrocytes (Martynoga et al., 2012; Sanosaka et al., 2008) . Although miR-31 was detected in both cell types, the levels of miR-31 were significantly higher in astrocytes (Figure 2d ). The identity of NPCs and astrocytes were confirmed by qRT-PCR and flow cytometry using Olig2, Nestin and SOX2 as NPC markers and GFAP as a marker of astrocytes (data not shown). Collectively, these data indicate that the levels of miR-31 become elevated in the developing CNS, and that miR-31 expression is predominantly in astrocytes.
| MiR-31 is induced during differentiation
In order to assess the role of miR-31 during astrocytogenesis in vitro, E14.5 NPCs were cultured in the absence or presence of 10% FBS for 3 days in order to induce astrocyte differentiation (Obayashi, Tabunoki Immunofluorescence of NPCs grown as described in (a) using antibodies specific for SOX2 (stem cell marker; green) or GFAP (astrocyte marker; red). Nuclei were counterstained with DAPI. (c-f) RNA from NPCs grown as described in (a) was analyzed by qRT-PCR. (**p < .001). (g) Protein levels from cells grown as described in (a) were analyzed by immunoblotting using the antibodies specified. (h and i) NPCs (E14.5) were grown in the absence (UT) or presence of LIF (10 ng/ml), BMP2 (10 ng/ml), LIF plus BMP or 10% FBS for 3 days to induce astrocyte differentiation. (h) RNA levels from NPCs grown as described above were evaluated by qRT-PCR. (**p < .001). (i) Protein levels from cells grown as described above were evaluated by immunoblotting using the antibodies specified. (j) The MIR31HG promoter spans 1,476 bp and contains six (1-6) evolutionarily conserved regions (ECRs; indicated in red) upstream of the transcriptional start site (TSS). Below each ECR is the size in bps, percent homology between murine and human sequences, and putative transcription factor binding sites present in each area. (k-q) Normal murine NPCs (E14.5) were grown in the absence (UT) or presence of 10% FBS to induce astrocyte development, and ChIP assays were performed using the antibodies indicated. Samples were evaluated by qRT-PCR. (*p < .05; **p < .001) [Color figure can be viewed at wileyonlinelibrary.com] (Figure 3a , untreated; UT), and express SOX2 (stem cell marker), but only modest GFAP (astrocyte marker; Figure 3b , UT). After FBS treatment, NPCs adopt a flattened, adherent morphology (Figure 3a, FBS) , lose SOX2 reactivity and differentiate into GFAP 1 astrocytes (Figure   3b , FBS). We confirmed that GFAP levels were significantly elevated, while those of stem cell markers were significantly reduced (Figure 3c e,g) via qRT-PCR and immunoblotting. The GFAP gene is expressed as multiple alternatively spliced isoforms (Figure 3g ; Thomsen, Daugaard, Holm, & Nielsen, 2013) ; presently, the significance of these other isoforms is not yet clear. Importantly, we determined miR-31 levels increased as NPCs differentiated into astrocytes (Figure 3f ). To confirm miR-31 levels increase regardless of the method used to differentiate NPCs into astrocytes, NPCs were left untreated (UT) or treated with LIF, BMP2, BMP2 1 LIF, or FBS (Lee et al., 2008) . Alone, LIF modestly increased miR-31 levels, while BMP2 alone or BMP2 1 LIF increased miR-31 to levels comparable to cells treated with 10% FBS (Figure 3h ).
The levels of miR-31 expression were positively correlated with GFAP expression, and inversely correlated with the levels of Lin28 (Figure 3i ).
These data confirm miR-31 is induced during astrocyte differentiation.
| MiR-31 is regulated by transcription factors that regulate NPC-to-astrocyte differentiation
To understand what factors might regulate miR-31 expression, evolutionarily conserved regions (ECR) Browser (www.ecrbrowser.dcode.
org) compared mouse and human genomes to identify ECR within the MIR31HG promoter; we identified six ECR (Figure 3j 
| Ectopic miR-31 expression induces partial astrocyte differentiation
To assess whether miR-31 promotes or merely coincides with astrocyte differentiation, NPCs were transfected with either control miR (CT) or miR-31; we confirmed miR-31 was expressed (Figure 4a ), and that this coincided with increased levels of GFAP mRNA ( Figure 4b) and protein (Figure 4e ), and reduced levels of Nestin and Lin28 ( Figure   4c -e); in Figure 4e , multiple alternatively spliced GFAP isoforms are detected (Thomsen et al., 2013) . Thus, exogenous miR-31 produces changes in gene expression associated with astrocyte differentiation.
To assess whether miR-31 is required for astrocyte differentiation, NPCs were transfected with CT miR or AntagomiR-31, and then left untreated (UT) or differentiated into astrocytes using 10% FBS (FBS).
FBS significantly increased the levels of miR-31 ( Figure 4f ) and GFAP (Figure 4g,h) , and reduced the levels of Lin28 (Figure 4h ) in NPCs expressing CT miR. However, if miR-31 expression was blocked ( Figure   4f ), changes indicative of astrocyte specification, including elevated and reduced levels of GFAP (Figure 4g ,h) and Lin28, respectively, ( Figure   4h ) were impaired. Astrocytogenesis is accompanied by morphological changes including the formation of astrocytic processes (Bolego et al., 1997; Lippman, Lordkipanidze, Buell, Yoon, & Dunaevsky, 2008) .
Therefore, we measured the length and counted the number of astrocytic processes in NPCs transfected with CT miR or miR-31 after 7 days. Cells transfected with miR-31 exhibited significantly more, but shorter, astrocytic processes per cell than those with CT miR (Figure 4i , j). Collectively, these data suggest miR-31 can promote, in part, astrocyte development.
| MiR-31 is required for astrocyte specification
Next, we tested whether miR-31 is required for astrocyte specification.
Normal murine astrocytes (P0) were transfected with CT miR or AntagomiR-31 (A) for 7 days, and then analyzed by immunofluorescence and immunoblotting. The levels of GFAP were significantly reduced in astrocytes that lacked miR-31 (Antagomir; A; Figure 5a , lower panel; Figure 5b) ; additionally, cells appeared rounded in shape presence of IL-1b; this activates NF-jB and increases the levels of both Lin28 (Iliopoulos, Hirsch, & Struhl, 2009 ) and miR-31 (Rajbhandari et al., 2015) . NF-jB induced Lin28 expression was more pronounced in cells that lack miR-31 (A) compared with those that express miR-31 (UT; Figure 5c ).
Next, we evaluated how the loss of miR-31 might impact the health of astrocytes; cells were transfected with CT miR (CT), miR-31 or AntagomiR-31 for various times (0-9 days) and cell metabolism was evaluated using the WST-1 assay. The metabolic profiles of astrocytes transfected with CT or miR-31 were nearly indistinguishable, suggesting CT and miR-31 did not adversely astrocytic health (Figure 5d ). Conversely, the metabolism of astrocytes lacking miR-31 (AntagomiR) was significantly reduced (Figure 5d ), and this coincided with loss of astrocytic processes and attachment as noted above (Figure 5a , data not shown). These data suggest that loss of miR-31 in astrocytes may prevent astrocyte maturation and adversely impact the health of astrocytes.
| Loss of Lin28 expression promotes astrocyte development
MiR targets mRNA to reduce gene expression; therefore, we reasoned miR-31 may target 1 or more stem cell factors to promote astrocyte differentiation. Above, we determined the levels of miR-31 were inversely correlated with Lin28, Oct4, SOX2, and C-myc; of these, only the Lin28 mRNA contained three miR-31 elements (Figure 6a ).
Immunoblots confirmed that the levels of Lin28 ( qRT-PCR assays were performed. These studies were performed in U251-MG cells as they constitutively express miR-31; moreover, TNFa induced NF-jB further elevates the levels of Lin28 expression and miR-31 (Iliopoulos et al. 2009; Rajbhandari et al. 2015) . Equal amounts of protein were immunoprecipitated (IP'd) with control antibodies (IgG) or antibodies specific for Lin28 (Lin28), and co-IP'd RNA was purified and analyzed for miR-31 using qRT-PCR. As shown in Figure 7d , miR-31 associated with Lin28, but not control IgG. When bound to Lin28, miRs are not free to bind target mRNA; these data suggest that Lin28 may "soak-up" any residual miR-31 levels in order to prevent NPC to astrocyte differentiation.
| D I SCUSSION
Herein, we present data demonstrating the temporal and spatial expression pattern of miR-31 within the developing CNS. We find miR-31 is expressed in most cells of the developing CNS, but its levels are most profound in astrocytes. We find NPCs utilize stem cell transcription factors to block the miR-31 promoter in order to maintain low levels of miR-31; additionally, NPCs modify DNA and histones (EZH2, H3K27Me3) to inhibit miR-31 transcription. Should any residual miR-31 be expressed, we found that the RNA-binding protein Lin28 bound to and inhibited miR-31 (Figure 8 ). From these data, we can speculate that miR-31 expression and/or activity must be blocked in NPCs in order to avoid premature astrocytogenesis. Indeed, during astrocyte specification, STAT3 and BMP1/5/8 become activated and bind to the miR-31 promoter; this coincides with diminished levels of suppressive factors and motifs, and correlates with an increase in the levels of miR-31. The ChIP data directly demonstrate that STAT3 and BMP1/5/8 drive miR-31 expression during astrocytogenesis. We demonstrate miR-31 is a key player during astrocyte specification. Alone, miR-31 is competent to partially induce astrocytogenesis; conversely, in the absence of miR-31, NPCs are unable to completely differentiate into astrocytes. From these data, we hypothesize that miR-31 is important for directly promoting astrocyte differentiation. In mature astrocytes, we determined the loss of miR-31 induced morphological and phenotypic changes that altered cellular phenotype and permitted markers of earlier developmental stages to be expressed. These data suggest miR-31 may be required to "lock" astrocytes into this identity. Finally, we determined miR-31 targets the stem cell factor and RNA-binding protein Lin28; additionally, miR-31 may promote astrocyte development, in part, by suppressing Lin28 expression.
Astrocytes are the most abundant cell type in the mammalian CNS . In mice, astrocyte production begins after the neurogenic-to-gliogenic switch, but is most prominent at P0-P14 (Nakayama, Sai, Otsu, Momoki-Soga, & Inoue, 2006; Setoguchi et al., 2006; Yanagisawa et al., 2000; Yanagisawa et al., 2001 ). Astrocytes provide structural support, maintain water balance and ion distribution, and help establish the blood-brain barrier (BBB) . During injury or disease, astrocytes help restore homeostasis to the microenvironment (Gallo & Deneen, 2014) . Astrocytes have been implicated in nearly all cases of CNS injury, degeneration and disease (Gallo & Deneen, 2014) . However, exactly how NPCs differentiate into astrocytes is not fully known.
Several transcription factors, including NFIA, STAT3, and SMAD1/ 5/8, have been implicated in astrocytogenesis (Glasgow et al., 2013; Glasgow et al., 2014a; Lee et al., 2014; Urayama et al., 2013; Yanagisawa et al., 2000) . However, few studies have addressed the role of noncoding factors, such as miRs, and their potential contribution towards astrocytogenesis (Cacci, Negri, Biagioni, & Lupo, 2017; Jovicic & Gitler, 2017; Karthikeyan, Patnala, Jadhav, Eng-Ang, & Dheen, 2016; Li et al., 2016; Rao et al., 2016; Smith et al., 2010; Yun et al., 2010) . By comparison, more is known about the contributions of miRs during neurogenesis (Boutz, Chawla, Stoilov, & Black, 2007; Choi et al., 2008; Hobert, 2006; Johnston, Chang, Etchberger, Ortiz, & Hobert, 2005; Kuss & Chen, 2008; Makeyev, Zhang, Carrasco, & Maniatis, 2007; Sempere et al., 2004) . Therefore, our study is significant as it identifies miR-31 as a potent mediator of astrocyte development. In our previous work, we determined that one or more alleles of miR-31 is deleted in GBM (Rajbhandari et al., 2015) . We hypothesize that the loss of miR-31 prevents normal astrocyte development and likely contributes to and/or worsens GBM tumorigencity (Rajbhandari et al., 2015) . Our studies also highlight the important role cell-specific miRs mediate during lineage specification, and underscore the need to determine whether these miRs are involved in disease formation/progression.
Ideally, other investigators and future studies will help address the role (s) of miRs in astrocyte development and disease.
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